Cited by 355Liver Disease and TransplantationSepsis Diagnosis and TreatmentAlcohol Consumption and Health Effects

The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.

Endotoxemia in patients with chronic liver diseases: relationship to severity of liver diseases, presence of esophaegeal varices, and hyperdynamic circulation.

Lin, Ren-Shin, Lee, Fa-Yauh, Lee, Shou-Dong, Tsai, Yang-Te, Lin, Han Chieh, Rei-Hwa, Lu, Wan-Ching, Hsu, Cheng-Chun, Huang, Sun-Sang, Wang, Kwang-Juei, Lo·1995·Journal of Hepatology

DOI 10.1016/0168-8278(95)80424-2

Open this paper in CoChat — free account

Abstract

Plasma endotoxin levels were investigated using a quantitative Limulus assay in patients with chronic liver diseases and correlated with the severity of liver diseases, the presence of esophageal varices, and hemodynamic parameters. The plasma endotoxin levels were significantly higher in chronic hepatitis patients with acute exacerbation (10.1 +/- 1.3 pg/ml, n = 13, p < 0.05) and patients with cirrhosis (7.0 +/- 0.7 pg/ml, n = 126, p < 0.05) than in healthy subjects (2.9 +/- 0.2 pg/ml, n = 45). Chronic hepatitis patients (n = 30) had plasma endotoxin levels which were similar to those in healthy subjects (4.6 +/- 0.5 vs. 2.9 +/- 0.2 pg/ml, p > 0.05) but lower than those in chronic hepatitis patients with acute exacerbation (4.6 +/- 0.5 vs. 10.1 +/- 1.3 pg/ml, p < 0.05). Endotoxemia (plasma endotoxin level > 5.7 pg/ml) was found in 27%, 85% and 41% of patients with chronic hepatitis, chronic hepatitis with acute exacerbation, and cirrhosis, respectively. In patients with cirrhosis, the plasma endotoxin levels progressively increased in relation to the severity of liver dysfunction (Pugh's class A/B/C = 4.9 +/- 0.5/7.9 +/- 1.4/10.2 +/- 2.0 pg/ml, p < 0.05). In contrast, plasma endotoxin levels were comparable between patients with cirrhosis with and without esophageal varices (p > 0.05). Chronic hepatitis patients with acute exacerbation (no collaterization) had much higher plasma endotoxin levels than those in patients with cirrhosis and large varices (p < 0.05), whereas compensated patients with cirrhosis and large esophageal varices had plasma endotoxin levels similar to those seen in chronic hepatitis patients (no collaterization) (p > 0.05).(ABSTRACT TRUNCATED AT 250 WORDS)

Integrity signals

Registry

Crossref · 10.1016/0168-8278(95)80424-2

Cites

40 of 40 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Transection of the oesophagus for bleeding oesophageal varices
Pugh, R. N. H., Murray-Lyon, I. M., Dawson, J. L., Pietroni, M. C., & Williams, R. (1973) · Journal of British Surgery · doi:10.1002/bjs.1800600817 · Cited by 7,941
Peripheral arterial vasodilation hypothesis: A proposal for the initiation of renal sodium and water retention in cirrhosis
Schrier, R. W., Arroyo, V., Bernardi, M., Epstein, M., Henriksen, J. H., & Rodés, J. (1988) · Hepatology · doi:10.1002/hep.1840080532 · Cited by 1,616
Biosynthesis of nitric oxide from l-arginine
Moncada, S., Palmer, R. M. J., & Higgs, E. A. (1989) · Biochemical Pharmacology · doi:10.1016/0006-2952(89)90403-6 · Cited by 1,222
The cardiovascular response of normal humans to the administration of endotoxin.
Suffredini, A., Fromm, R., Parker, M., Brenner, M., Kovacs, J., Wesley, R., & Parrillo, J. (1989) · New England Journal of Medicine · doi:10.1056/nejm198908033210503 · Cited by 1,133
Prediction of variceal hemorrhage by esophageal endoscopy
Beppu, K., Inokuchi, K., Koyanagi, N., Nakayama, S., Sakata, H., Kitano, S., & Kobayashi, M. (1981) · Gastrointestinal Endoscopy · doi:10.1016/s0016-5107(81)73224-3 · Cited by 758
Hyperdynamic circulation in cirrhosis: A role for nitric oxide?
Vallance, P., & Moncada, S. (1991) · The Lancet · doi:10.1016/0140-6736(91)91384-7 · Cited by 615
Dexamethasone prevents the induction by endotoxin of a nitric oxide synthase and the associated effects on vascular tone: An insight into endotoxin shock
Rees, D. D., Cellek, S., Palmer, R. M. J., & Moncada, S. (1990) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(05)80068-3 · Cited by 590
Thermodilution cardiac output determination with a single flow-directed catheter
Forrester, J. S., Ganz, W., Diamond, G. A., McHugh, T., Chonette, D., & Swan, H. J. C. (1972) · American Heart Journal · doi:10.1016/0002-8703(72)90429-2 · Cited by 500
Increased serum nitrite and nitrate levels in patients with cirrhosis: relationship to endotoxemia
Guarner, C., Soriano, G., Tomas, A., Bulbena, O., Novella, M. T., Balanzo, J., Vilardell, F., Mourelle, M., & Moncada, S. (1993) · Hepatology · doi:10.1002/hep.1840180520 · Cited by 489
Plasma endotoxin concentrations in patients with alcoholic and non-alcoholic liver disease: reevaluation with an improved chromogenic assay
Fukui, H., Brauner, B., Bode, J. C., & Bode, C. (1991) · Journal of Hepatology · doi:10.1016/0168-8278(91)90933-3 · Cited by 461

Show all 40 references

Sorted by citations

Items 201–300 of 355

Gut microbiome in non-alcoholic fatty liver disease associated hepatocellular carcinoma: Current knowledge and potential for therapeutics
Said, I., Ahad, H., & Said, A. (2022) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v14.i5.947 · Cited by 27
Nonalcoholic Fatty Liver Disease
Sanyal, A. J. (2004) · Clinics in Liver Disease · doi:10.1016/j.cld.2004.04.014 · Cited by 53
Contribution of the Gut Microbiota to Intestinal Fibrosis in Crohn's Disease
Watanabe, D., & Kamada, N. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.826240 · Cited by 23
Von Willebrand Factor as a Biomarker for Liver Disease – An Update
Elhence, A., & Shalimar, S. (2023) · Journal of Clinical and Experimental Hepatology · doi:10.1016/j.jceh.2023.05.016 · Cited by 23
Low Levels of Microbial Translocation Marker LBP Are Associated with Sustained Viral Response after Anti-HCV Treatment in HIV-1/HCV Co-Infected Patients
Nyström, J., Stenkvist, J., Häggblom, A., Weiland, O., & Nowak, P. (2015) · PLoS ONE · doi:10.1371/journal.pone.0118643 · Cited by 24
Expression of Toll‐like receptor 4 in rat liver during the course of carbon tetrachloride‐induced liver injury
Hua, J., Qiu, D., Li, J. Q., Eng Ling, L. I., Chen, X. Y., & Peng, Y. S. (2007) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2007.04896.x · Cited by 23
Intestinal Fibrosis and Liver Fibrosis: Consequences of Chronic Inflammation or Independent Pathophysiology?
Rieder, F., Bettenworth, D., Imai, J., & Inagaki, Y. (2016) · Inflammatory Intestinal Diseases · doi:10.1159/000445135 · Cited by 25
Cirrhotic Patients Admitted to the ICU With Septic Shock: Factors Predicting Short and Long-Term Outcome
Baudry, T., Hernu, R., Valleix, B., Jahandiez, V., Faucher, E., Simon, M., Cour, M., & Argaud, L. (2018) · Shock · doi:10.1097/shk.0000000000001282 · Cited by 23
Changes in the gut microbiota after hepatitis C virus eradication
Honda, T., Ishigami, M., Yamamoto, K., Takeyama, T., Ito, T., Ishizu, Y., Kuzuya, T., Nakamura, M., Kawashima, H., Miyahara, R., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-03009-0 · Cited by 23
Attenuation of Congenital Portosystemic Shunt Reduces Inflammation in Dogs
Tivers, M., Handel, I. G., Gow, A. G., Lipscomb, V. J., Jalan, R., & Mellanby, R. J. (2015) · PLoS ONE · doi:10.1371/journal.pone.0117557 · Cited by 23
Molecular Immune Mechanism of Intestinal Microbiota and Their Metabolites in the Occurrence and Development of Liver Cancer
Bi, C., Xiao, G., Liu, C., Yan, J., Chen, J., Si, W., Zhang, J., & Liu, Z. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.702414 · Cited by 25
Superimposed Coagulopathic Conditions in Cirrhosis: Infection and Endogenous Heparinoids, Renal Failure, and Endothelial Dysfunction
Smalberg, J. H., & Leebeek, F. W. G. (2009) · Clinics in Liver Disease · doi:10.1016/j.cld.2008.09.006 · Cited by 22
Increased EMR2 expression on neutrophils correlates with disease severity and predicts overall mortality in cirrhotic patients
Huang, C., Jeng, W., Ho, Y., Teng, W., Hsieh, Y., Chen, W., Chen, Y., Lin, H.-H., Sheen, I., & Lin, C. (2016) · Scientific Reports · doi:10.1038/srep38250 · Cited by 22
Self-citation
Immune function biomarker QuantiFERON-monitor is associated with infection risk in cirrhotic patients
Sood, S. S., Yu, L., Visvanathan, K., Angus, P., Gow, P. J., & Testro, A. (2016) · World Journal of Hepatology · doi:10.4254/wjh.v8.i35.1569 · Cited by 22
Evaluation of bacterial translocation in patients with chronic HCV infection.
Munteanu, D., Negru, A., Radulescu, M. A., Mihăilescu, R., Ss, A., & Aramă, V. (2014) · PubMed · Cited by 21
Elevated serum tumor necrosis factor-α and soluble tumor necrosis factor receptors correlate with aberrant energy metabolism in liver cirrhosis
Shiraki, M., Terakura, Y., Iwasa, J., Shimizu, M., Miwa, Y., Murakami, N., Nagaki, M., & Moriwaki, H. (2009) · Nutrition · doi:10.1016/j.nut.2009.04.016 · Cited by 20
Lipopolysaccharide binding protein in cirrhotic patients with severe sepsis
Chen, Y., Lien, J., Peng, Y., Chen, Y., Tian, Y.-C., Fang, J., Huang, H.-C., Chen, P., Yang, C.-W., Wu, C., et al. (2013) · Journal of the Chinese Medical Association · doi:10.1016/j.jcma.2013.10.006 · Cited by 20
Regulating Hepatic Inflammation: Pathogen–Associated Molecular Patterns Take Their Toll
Iredale, J. P. (2003) · Hepatology · doi:10.1053/jhep.2003.50224 · Cited by 20
Amelioration of Hepatic Encephalopathy Using Dunaliella salina Microalgae in Rats: Modulation of Hyperammonemia/TLR4
El-Baz, F. K., Elgohary, R., & Salama, A. (2021) · BioMed Research International · doi:10.1155/2021/8843218 · Cited by 19
Identifying Novel Targets for Treatment of Liver Fibrosis: What Can We Learn from Injured Tissues which Heal Without a Scar?
Pritchard, M. T., & McCracken, J. M. (2015) · Current Drug Targets · doi:10.2174/1389450116666150825111439 · Cited by 19
Targeting anti-fibrotic pathways in Crohn’s disease – The final frontier?
Ma, C., Jairath, V., Click, B. H., Hirota, S. A., Lu, C., Parker, C. E., & Rieder, F. (2019) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2019.02.005 · Cited by 19
The gut-liver axis in hepatobiliary diseases
Ichikawa, M., Okada, H., Nakamoto, N., Taniki, N., Chu, P., & Kanai∥, T. (2024) · Inflammation and Regeneration · doi:10.1186/s41232-023-00315-0 · Cited by 19
Attenuated fibrosis in specific pathogen‐free microbiota in experimental cholestasis‐ and toxin‐induced liver injury
Moghadamrad, S., Hassan, M., McCoy, K. D., Kirundi, J., Kellmann, P., & Gottardi, A. D. (2019) · The FASEB Journal · doi:10.1096/fj.201901113r · Cited by 18
Lycopene attenuates LPS-induced liver injury by inactivation of NF-κB/COX-2 signaling.
Dong, J., Li, W., Cheng, L.-M., & Wang, G. (2019) · Europe PMC (PubMed Central) · Cited by 18
Circulating levels of 3‐hydroxymyristate, a direct quantification of endotoxaemia in noninfected cirrhotic patients
Weil, D., de Barros, J.-P. P., Mourey, G., Laheurte, C., Cypriani, B., Badet, N., Delabrousse, É., Grandclément, É., Martino, V. D., Saas, P., et al. (2018) · Liver International · doi:10.1111/liv.13916 · Cited by 18
Plasma interleukin‐8 levels in patients with post‐hepatitic cirrhosis: Relationship to severity of liver disease, portal hypertension and hyperdynamic circulation
Li, C., LEE, F., Tsai, Y., Lin, H., Lu, R., HOU, M., WANG, T., Chen, L.-S., Wang, S.-S., & LEE, S. (1996) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.1996.tb00306.x · Cited by 16
Self-citation
Antioxidant protective effects of lactitol against endotoxemia in patients with chronic viral hepatitis
Chen, C., Yu, X., Lu, H., Xiao, D., Mao, W., & Li, L. (2012) · Molecular Medicine Reports · doi:10.3892/mmr.2012.1188 · Cited by 16
Urinary Metabolite Profiling Offers Potential for Differentiation of Liver-Kidney Yin Deficiency and Dampness-Heat Internal Smoldering Syndromes in Posthepatitis B Cirrhosis Patients
Wang, X., Xie, G., Wang, X., Zhou, M., Yu, H., Lin, Y., Du, G.-L., Luo, G., & Liu, P. (2015) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2015/464969 · Cited by 17
Targeting naproxen coupled to human serum albumin to nonparenchymal cells reduces endotoxin-induced mortality in rats with biliary cirrhosis
Albrecht, C., Meijer, D. K. F., Lebbé, C., Sägesser, H., Melgert, B. N., Poelstra, K., & Reichen, J. (1997) · Hepatology · doi:10.1002/hep.510260624 · Cited by 16
Recent Advances in the Pathogenesis and Clinical Evaluation of Portal Hypertension in Chronic Liver Disease
Kotani, K., & Kawada, N. (2023) · Gut and Liver · doi:10.5009/gnl230072 · Cited by 15
Portal Vein Thrombosis in Patients With Cirrhosis Undergoing Elective Transjugular Intrahepatic Portosystemic Shunt: Risk Factors, Warfarin Efficacy, and Clinical Outcomes
Wan, Y., Li, Y., Wu, H.-M., Yang, J., Yang, L., & Xu, Y. (2017) · Clinical and Applied Thrombosis/Hemostasis · doi:10.1177/1076029616689593 · Cited by 15
Elevated serum procalcitonin levels and their association with the prognosis of patients with liver cirrhosis
Sato, S., Sato, S., Tsuzura, H., Ikeda, Y., Hayashida, S., Takahashi, S., Amano, N., Murata, A., Shimada, Y., Iijima, K., et al. (2019) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000001644 · Cited by 15
Nonalcoholic Fatty Liver Disease
Patel, V. A., & Sanyal, A. J. (2013) · Springer eBooks · doi:10.1007/978-3-319-02096-9_23 · Cited by 15
Endotoxin measures in patients’ sample: How valid are the results?
Stadlbauer, V., Davies, N. A., Wright, G. A. K., & Jalan, R. (2007) · Journal of Hepatology · doi:10.1016/j.jhep.2007.08.001 · Cited by 15
Beneficial effect of refined red palm oil on lipid peroxidation and monocyte tissue factor in HCV-related liver disease: a randomizer controller study
Catanzaro, R., Zerbinati, N., Solimene, U., Marcellino, M. G., Mohania, D., Italia, A., Ayala, A., & Marotta, F. (2016) · Hepatobiliary & pancreatic diseases international · doi:10.1016/s1499-3872(16)60072-3 · Cited by 14
Basil Essential Oil and Its Nanoemulsion Mitigate Non Alcoholic Steatohepatitis in Rat Model with Special Reference to Gut Microbiota
Al‐Okbi, S. Y., Amin, M. A., Mohamed, A. E. A., Edris, A. E., Sharaf, O. M., Mabrok, H. B., & Ramadan, A. (2020) · Journal of Oleo Science · doi:10.5650/jos.ess20067 · Cited by 16
GUT MICROBIOTA, PREBIOTICS, PROBIOTICS, AND SYNBIOTICS IN GASTROINTESTINAL AND LIVER DISEASES: PROCEEDINGS OF A JOINT MEETING OF THE BRAZILIAN SOCIETY OF HEPATOLOGY (SBH), BRAZILIAN NUCLEUS FOR THE STUDY OF HELICOBACTER PYLORI AND MICROBIOTA (NBEHPM), AND BRAZILIAN FEDERATION OF GASTROENTEROLOGY (FBG)
Barbuti, R. C., Schiavon, L. D. L., de Oliveira, C. P. M. S., Álvares‐da‐Silva, M. R., Sassaki, L. Y., Passos, M. D. C. F., Farias, A. Q., Barros, L. L., Barreto, B. A. P., de Albuquerque, G. B. D. M. L., et al. (2020) · Arquivos de Gastroenterologia · doi:10.1590/s0004-2803.202000000-72 · Cited by 16
Inflammation and Hepatic Fibrosis, Then Hepatocellular Carcinoma
Kwon, O. S., Choi, S. H., & Kim, J. H. (2015) · Korean Journal of Gastroenterology · doi:10.4166/kjg.2015.66.6.320 · Cited by 13
Effect of oxidative stress and endotoxin on human serum albumin in brain-dead organ donors
Leber, B., Stadlbauer, V., Stiegler, P., Stanzer, S., Mayrhauser, U., Koestenbauer, S., Leopold, B., Sereinigg, M., Puntschart, A., Stojaković, T., et al. (2012) · Translational research · doi:10.1016/j.trsl.2011.12.005 · Cited by 13
A variant in the nuclear dot protein 52kDa gene increases the risk for spontaneous bacterial peritonitis in patients with alcoholic liver cirrhosis
Lutz, P. L., Krämer, B., Kaczmarek, D. J., Hübner, M. P., Langhans, B., Appenrodt, B., Lammert, F., Nattermann, J., Hoerauf, A. M., Strassburg, C. P., et al. (2015) · Digestive and Liver Disease · doi:10.1016/j.dld.2015.09.011 · Cited by 13
Nonalcoholic Fatty Liver Disease and the Intestinal Microbiome: An Inseparable Link
Effenberger, M., Grander, C., Grabherr, F., & Tilg, H. (2023) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2023.00069 · Cited by 14
Gut microbes associated with functional cure of chronic hepatitis B
Honda, T., Ishigami, M., Ishizu, Y., Imai, N., Ito, T., Yamamoto, K., Yokoyama, S., Muto, H., Inukai, Y., Kato, A., et al. (2025) · Hepatology International · doi:10.1007/s12072-025-10776-9 · Cited by 12
Vitamin E
Traber, M. G., & Bruno, R. S. (2020) · Elsevier eBooks · doi:10.1016/b978-0-323-66162-1.00007-x · Cited by 16
Hyperglucagonaemia in cirrhotic patients and its relationship to the severity of cirrhosis and haemodynamic values
Lin, H., Yang, M. C. M., HOU, M., LEE, F., Huang, Y., LIN, L., LI, S., Hwang, S., Wang, S.-S., Tsai, Y., et al. (1996) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.1996.tb00285.x · Cited by 12
Self-citation
Prostaglandin F2α modulates atrial chronotropic hyporesponsiveness to cholinergic stimulation in endotoxemic rats
Nikoui, V., Mehr, S. E., Jazaeri, F., Ostadhadi, S., Eftekhari, G., Dehpour, A. R., Mani, A. R., & Bakhtiarian, A. (2014) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2014.10.019 · Cited by 11
Should temporary extracorporeal continuous portal diversion replace meso/porta-caval shunts in “small-for-size” syndrome in porcine hepatectomy?
Wang, D.-D., Xu, Y. Z., Zhu, Z., Tan, X.-L., Tu, Y., Han, M., & Tan, J. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i3.888 · Cited by 11
Non-selective β-blockers in advanced cirrhosis: a critical review of the effects on overall survival and renal function
Algora, S. B., Ataz, J. M., Alonso, S., García, M. L. G., & Fernández‐Rodríguez, C. (2016) · BMJ Open Gastroenterology · doi:10.1136/bmjgast-2016-000104 · Cited by 11
Endothelin 1 aggravates acute liver injury in perfused livers of rats after treatment with d -galactosamine
Iwai, M., Yamauchi, T., & Shimazu, T. (1998) · Hepatology · doi:10.1002/hep.510280230 · Cited by 11
Hepatic Cirrhosis
McCormick, P. A. (2011) · doi:10.1002/9781444341294.ch7 · Cited by 11
Effect ofHelicobacter pyloriinfection on gastric mucosal pathologic change and level of nitric oxide and nitric oxide synthase
Wang, Y. (2005) · World Journal of Gastroenterology · doi:10.3748/wjg.v11.i32.5029 · Cited by 10
Evidence against a role for endotoxin in the hyperdynamic circulation of rats with prehepatic portal hypertension
Chu, C.-J., Lee, F., Wang, S.-S., Chang, F.-Y., Lin, H.-C., Lu, R. H., Wu, S.-L., Chan, C., Tai, C.-C., Lai, I.-N., et al. (1999) · Journal of Hepatology · doi:10.1016/s0168-8278(99)80266-9 · Cited by 10
Self-citation
Chronic-binge ethanol feeding aggravates systemic dyslipidemia in Ldlr-/- mice, thereby accelerating hepatic fibrosis
Hoebinger, C., Rajcic, D., Silva, B., & Hendrikx, T. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1148827 · Cited by 9
Prophylactic use of antibiotics in endoscopic injection of tissue adhesive for the elective treatment of gastric varices: A randomized controlled study
Liu, C., Ma, L., Wang, J., Li, F., Tseng, Y., Luo, T., Zeng, X., & Chen, S. (2019) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.14769 · Cited by 9
Nonalcoholic fatty liver disease as trigger of cardiovascular and metabolic complication in metabolic syndrome
Miele, L., Gasbarrini, A., Giorgio, V., Gasbarrini, A., & Grieco, A. (2015) · Internal and Emergency Medicine · doi:10.1007/s11739-015-1346-x · Cited by 9
Impact of Functional Hepatic Venous Outflow Obstruction on Perioperative Outcome After Living-Donor Liver Transplant
Appukuttan, M., Kumar, S., V, Bharathy, K. G. S., Pandey, V. K., & Pamecha, V. (2018) · Experimental and Clinical Transplantation · doi:10.6002/ect.2017.0138 · Cited by 9
Gut microbiota contribution to hepatocellular carcinoma manifestation in non-alcoholic steatohepatitis
Liakina, V., Strainienė, S., Stundienė, I., Maksimaityte, V., & Kazėnaitė, E. (2022) · World Journal of Hepatology · doi:10.4254/wjh.v14.i7.1277 · Cited by 11
Genetic variation in TNFA predicts protection from severe bacterial infections in patients with end-stage liver disease awaiting liver transplantation
Šenkeříková, R., de Mare-Bredemeijer, E., Fraňková, S., Roelen, D. L., Visseren, T., Trunečka, P., Špičák, J., Metselaar, H. J., Jirsa, M., Kwekkeboom, J., et al. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.12.011 · Cited by 9
Elevated Soluble Tumour Necrosis Factor Receptor Serum Concentrations and Short-Term Mortality in Liver Cirrhosis without Acute Infections
Reichel, C., Sudhop, T., Braun, B., Kreuzer, K., Hahn, C., Look, M. P., von Bergmann, K., Sauerbruch, T., & Spengler, U. (2000) · Digestion · doi:10.1159/000007777 · Cited by 9
Effect of Chronic Bile Duct Obstruction and LPS Upon Targeting of Naproxen to the Liver Using Naproxen-Albumin Conjugate
Albrecht, C., Melgert, B. N., Reichen, J., Poelstra, K., & Meijer, D. K. F. (1998) · Journal of drug targeting · doi:10.3109/10611869808997886 · Cited by 9
Toll-like receptor signaling in the liver
Seki, E., Brenner, D. A., & Schwabe, R. F. (2006) · Birkhäuser Basel eBooks · doi:10.1007/3-7643-7441-1_7 · Cited by 9
Beneficial changes in total cholesterol, LDL-C, biomarkers of intestinal inflammation, and vitamin E status in adults with metabolic syndrome consuming almonds as snack foods: a randomized controlled clinical trial
Beaver, L. M., Leonard, S. W., Uesugi, S. L., Wong, C. P., Lytle, L.-M., Vasudevan, A., Papenhausen, E. M., Jupudi, Y., Bella, D. L., Bobe, G., et al. (2025) · Nutrition Research · doi:10.1016/j.nutres.2025.04.011 · Cited by 10
Proton pump inhibitor treatment is associated with acute-on-chronic liver failure in patients with advanced cirrhosis
Sturm, L., Gahm, C., Schultheiß, M., Reincke, M., Huber, J. P., Boettler, T., Thimme, R., & Bettinger, D. (2023) · Hepatology Communications · doi:10.1097/hc9.0000000000000178 · Cited by 8
Proton pump inhibitor treatment aggravates bacterial translocation in patients with advanced cirrhosis and portal hypertension
Sturm, L., Hirose, M., Stolz, L., Schultheiß, M., Zoldan, K., Reincke, M., Huber, J. P., Kaeser, R., Boettler, T., Thimme, R., et al. (2023) · mBio · doi:10.1128/mbio.00492-23 · Cited by 8
Overexpression of pim-3 and protective role in lipopolysaccharide-stimulated hepatic stellate cells
Liu, L. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i29.8858 · Cited by 8
Lipopolysaccharide and toll-like receptor 4 in dogs with congenital portosystemic shunts
Tivers, M., Lipscomb, V. J., Smith, K. C., Wheeler-Jones, C. P. D., & House, A. K. (2015) · The Veterinary Journal · doi:10.1016/j.tvjl.2015.07.006 · Cited by 9
Inhibition of prostacyclin by indomethacin ameliorates the splanchnic hyposensitivity to glypressin in haemorrhage‐transfused common bile duct‐ligated rats
LEE, F., Chu, C. ‐., Wang, S.-S., Chang, F. ‐., Lin, H.-C., Hou, M., Chan, C. ‐., Wu, S.-L., Chen, C. ‐., Huang, H., et al. (2001) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2001.00764.x · Cited by 8
Self-citation
Macrophages from rat livers with micronodular and macronodular cirrhosis differ with respect to mediator release and DNA-synthesis
Vogl, S., Junker, U., Vogelsang, H., & Dargel, R. (1997) · Journal of Hepatology · doi:10.1016/s0168-8278(97)80118-3 · Cited by 8
The liver’s dilemma: sensing real danger in a sea of PAMPs: the (arterial) sinusoidal segment theory
Henriques‐Pons, A., Vacani-Martins, N., dos Santos, C. D. L. P., & Meuser-Batista, M. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1503063 · Cited by 8
Cirrhosis and Faecal microbiota Transplantation (ChiFT) protocol: a Danish multicentre, randomised, placebo-controlled trial in patients with decompensated liver cirrhosis
Støy, S. H., Eriksen, L. L., Lauszus, J. S., Damsholt, S., Baunwall, S. M. D., Erikstrup, C., Vilstrup, H., Jepsen, P., Hvas, C. L., & Thomsen, K. L. (2025) · BMJ Open · doi:10.1136/bmjopen-2024-091078 · Cited by 7
Crosstalk between Gut Microbiota and Hepatocellular Carcinoma
Xie, C., & Pocha, C. (2023) · Gastrointestinal Disorders · doi:10.3390/gidisord5020013 · Cited by 7
Intratumoral microbiota: an emerging force in diagnosing and treating hepatocellular carcinoma
Liu, H., Zhang, J., Rao, Y., Jin, S., Zhang, C., & Bai, D. (2024) · Medical Oncology · doi:10.1007/s12032-024-02545-9 · Cited by 9
The portal vein as a distinct immunological compartment – A comprehensive immune phenotyping study
Queck, A., Rueschenbaum, S., Kubesch, A., Cai, C., Zeuzem, S., Weigert, A., Brüne, B., Nour-Eldin, N.-E. A., Gruber‐Rouh, T., Vogl, T. J., et al. (2018) · Human Immunology · doi:10.1016/j.humimm.2018.07.233 · Cited by 7
Impaired antibacterial response of liver sinusoidal Vγ9+Vδ2+ T cells in patients with chronic liver disease
Rha, M., Han, J. W., Koh, J., Lee, H. S., Kim, J. H., Cho, K., Kim, S. I., Kim, M. S., Lee, J. G., Park, S., et al. (2021) · Gut · doi:10.1136/gutjnl-2020-322182 · Cited by 7
Influence of Gut–Liver Axis on Portal Hypertension in Advanced Chronic Liver Disease: The Gut Microbiome as a New Protagonist in Therapeutic Management
Santopaolo, F., Coppola, G., Giuli, L., Gasbarrini, A., & Ponziani, F. R. (2022) · Microbiology Research · doi:10.3390/microbiolres13030038 · Cited by 8
Markers of immunity and bacterial translocation in cirrhosis.
Mortensen, C. (2015) · PubMed · Cited by 7
Mesenchymal Stem Cells Induce a Fibrolytic Phenotype By Regulating mmu-miR-6769b-5p Expression in Macrophages
Nishi, M., Matsumoto, T., Fujisawa, K., Suehiro, Y., Takami, T., Yamamoto, N., Yamasaki, T., & Sakaida, I. (2020) · Stem Cells and Development · doi:10.1089/scd.2020.0123 · Cited by 8
The intestinal microbiota and hepatocellular carcinoma
Effenberger, M., & Tilg, H. (2020) · memo - Magazine of European Medical Oncology · doi:10.1007/s12254-020-00597-x · Cited by 6
Hepatorenal syndrome and ascites — an introduction
Geñtilini, P. (1999) · Liver International · doi:10.1111/j.1478-3231.1999.tb00091.x · Cited by 7
Aluminum-induced oxidative stress promotes changes in the structure of the gut microbiota and liver deficiency
Feng, R., Chen, L., & Yang, M. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e36165 · Cited by 7
Serotonin Metabolism Parameters in Patients with Chronic Hepatitis and Liver Cirrhosis
Alekseeva, A. S., Éi, B., Игоревич, Р. М., Naumova, E. L., Lambrov, E. G., & Philippova, L. P. (2008) · Bulletin of Experimental Biology and Medicine · doi:10.1007/s10517-009-0353-1 · Cited by 6
Elevated plasma phage load as a marker for intestinal permeability in leukemic patients
Yin, X., Liu, P., Xu, X., Xia, Y., Huang, K., Wang, Q., Lai, M., Yu, Q., & Zheng, X. (2020) · Medical Microbiology and Immunology · doi:10.1007/s00430-020-00694-y · Cited by 6
Allopurinol Prevents Cirrhosis-Related Complications: A Quadruple Blind Placebo-Controlled Trial
Glal, K. A. M., El-Haggar, S. M., Abd-Elsalam, S. M., & Mostafa, T. M. (2023) · The American Journal of Medicine · doi:10.1016/j.amjmed.2023.09.016 · Cited by 6
Endotoxin exacerbates immunologically induced liver injury in cooperation with interferon- γ
Chen, X., Cao, J., & Xu, Q. (2000) · Inflammation Research · doi:10.1007/s000110050633 · Cited by 6
Heparin effect on thromboelastography after transjugular intrahepatic portosystemic shunt procedure
Thalheimer, U., Triantos, C. K., Samonakis, D. N., Patch, D., & Burroughs, A. K. (2009) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365520903342174 · Cited by 6
Increased hepatic expression of nitric oxide synthase type II in cirrhotic rats
Wang, H. (2004) · World Journal of Gastroenterology · doi:10.3748/wjg.v10.i13.1923 · Cited by 6
Current advances in the management of hepatic encephalopathy: an updated and critical review
El‐Mansoury, B., Esselmani, H., Merzouki, M., Ezhilarasan, D., Hiba, O. E., Ortega, A., & Najimi, M. (2025) · Pharmacological Reports · doi:10.1007/s43440-025-00786-7 · Cited by 5
Altered gut microbial functional pathways in people with irritable bowel syndrome enable precision health insights
Patridge, E. V., Gorakshakar, A., Molusky, M. M., Ogundijo, O., Julian, C., Hu, L., Antoine, G., Vuyisich, M., Wohlman, R., & Banavar, G. S. (2025) · BMC Gastroenterology · doi:10.1186/s12876-025-04205-2 · Cited by 5
The effect of propranolol on gastrointestinal motility and permeability in patients with cirrhosis and significant portal hypertension
Xirouchakis, E., Kranidioti, H., Hadziyanni, E., Κourikou, A., Reppas, C. I., Vertzoni, M., Papadopoulos, N., Deutsch, M. J., Papatheodoridis, G., & Manolakopoulos, S. (2024) · BMC Gastroenterology · doi:10.1186/s12876-024-03483-6 · Cited by 5
Rifaximin Improves Liver Functional Reserve by Regulating Systemic Inflammation
Kitsugi, K., Kawata, K., Noritake, H., Chida, T., Ohta, K., Ito, J., Takatori, S., Yamashita, M., Hanaoka, T., Umemura, M., et al. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12062210 · Cited by 5
Effect of Liver Fibrosis on Oral and Gut Microbiota in the Japanese General Population Determined by Evaluating the FibroScan–Aspartate Aminotransferase Score
Sato, S., Iino, C., Chinda, D., Sasada, T., Tateda, T., Kaizuka, M., Nomiya, H., Igarashi, G., Sawada, K., Mikami, T., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241713470 · Cited by 5
Microbial Translocation in the Context of Hepatitis B Infection and Hepatitis D Infection
Townsend, E. C., Zhang, G. Y., Ali, R., Surana, P., Firke, M., Moon, M. S., Han, M. A. T., Gewirtz, M. A., Haddad, J. A., Kleiner, D. E., et al. (2020) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofaa496 · Cited by 5
Existence and distribution of the microbiome in tumour tissues of children with hepatoblastoma
Cui, J.-H., Li, X., Zhang, Q., Du, B., Ding, Z., Yan, C., Xue, G.-H., Gan, L., Feng, J.-X., Fan, Z., et al. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e39547 · Cited by 4
Tissue factor expression on blood monocytes in patients with hepatitis C virus-induced chronic liver disease
El-Bassiouni, N. E., Elmessery, L. O., Zayed, R. A., Metwally, O. B., Zahran, M. Y., Mahmoud, O., Ibrahim, R. A., & Bassiouny, A. E. E. (2013) · Comparative Clinical Pathology · doi:10.1007/s00580-013-1757-x · Cited by 4
The Great Escape: Microbiotal LPS Takes a Toll on the Liver
Weiss, D. S. (2012) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-12-0248 · Cited by 4
TIPS with a polytetrafluoroethylene-lined stent graft and associated haemolytic anaemia.
Fallon, E., Ehrenwald, E., Nazarian, G. K., & Smith, C. (2008) · PubMed · Cited by 4
Hepato‐cellular Failure
Sherlock, F. S., & BSc, J. D. (2001) · doi:10.1002/9780470986820.ch6 · Cited by 4
The role of bacterial outer membrane vesicles in inflammatory response of acute-on-chronic liver failure
Qin, X., Wang, S., Yan, Z., Zhao, N., & Yao, J. (2025) · Frontiers in Microbiology · doi:10.3389/fmicb.2025.1608137 · Cited by 3
Adrenal Dysfunction in Portal Hypertensive Rats with Acute Hemorrhage
Lee, F., Wang, S.-S., Tsai, M.-H., Huang, H., Lin, H., & Lee, S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0092093 · Cited by 3
Self-citation
Upregulated Expression of A20 on Monocytes is Associated With Increased Severity of Acute-on-Chronic Hepatitis B Liver Failure
Guo, Y., He, Y., Zhang, Y., Zhou, Y., Qin, Y., Fan, C., Ji, G., Zhang, P., & Jia, Z. (2015) · Medicine · doi:10.1097/md.0000000000001501 · Cited by 3
Ethanol and Hepatocarcinogenesis
Seitz, H. K., & Stickel, F. (2012) · Humana Press eBooks · doi:10.1007/978-1-62703-047-2_32 · Cited by 3

Authors: Lin, R.-S., Lee, F.-Y., Lee, S.-D., Tsai, Y.-T., Lin, H. C., Rei-Hwa, L., Wan-Ching, H., Cheng-Chun, H., Sun-Sang, W., & Kwang-Juei, L.
Affiliations: Taipei Veterans General Hospital (TW)
National Yang Ming University (TW)
Corresponding author: Lee, Fa-Yauh
ORCID: Lee, Fa-Yauh
Lee, Shou-Dong
Lin, Han Chieh
Venue: Journal of Hepatology
Publisher: Elsevier BV
Published: 1995-02
Volume: 22
Issue: 2
Pages: 165-172
ISSN: 0168-8278 (ISSN-L)
DOI: 10.1016/0168-8278(95)80424-2
OpenAlex: W2155112010
Cited by: 355
References: 40
Citations by year: 2026: 4 · 2025: 10 · 2024: 8 · 2023: 19 · 2022: 15 · 2021: 16 · 2020: 23 · 2019: 16 · 2018: 11 · 2017: 14 · 2016: 16 · 2015: 31 · 2014: 13 · 2013: 14 · 2012: 27
FWCI: 4.26
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Journal of Hepatology (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Hepatology › Liver Disease and Transplantation
Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Sepsis Diagnosis and Treatment
Health Sciences › Medicine › Pathology and Forensic Medicine › Alcohol Consumption and Health Effects
Keywords: endotoxemia, plasma endotoxin, chronic liver disease, liver cirrhosis, chronic hepatitis, esophageal varices, hyperdynamic circulation, portal hypertension, acute exacerbation, liver dysfunction severity, collateral circulation
MeSH terms: Blood Circulation, Chronic Disease, Endotoxins, Esophageal and Gastric Varices, Female, Hepatitis, Humans, Liver Cirrhosis, Liver Diseases, Male, Middle Aged

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Endotoxemia in patients with chronic liver diseases: relationship to severity of liver diseases, presence of esophaegeal varices, and hyperdynamic circulation.

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks